Pradeep lived nearly 20 years without knowing he had PNH, relying on repeated blood transfusions without a diagnosis. His life changed in 2021 when he was finally diagnosed, and in 2024, he enrolled in a Phase-3 global clinical trial for Pozelimab + Cemdisiran. One year later, he is living a healthy, transfusion-free life — and now uses his voice to spread awareness, hope and the importance of timely diagnosis and access to advanced therapies.